Cassina de' Pecchi, Italy

Giovanni Battista Colombo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zambon Group. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giovanni Battista Colombo. Retrieved from https://idiyas.com/inventor/giovanni-battista-colombo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giovanni Battista Colombo: Innovator in Pharmaceutical Compositions

Introduction

Giovanni Battista Colombo is a notable inventor based in Cassina de' Pecchi, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections caused by Chlamydia pneumoniae. His innovative work has led to the development of valuable pharmaceutical compositions.

Latest Patents

Colombo holds a patent for the "Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections." This patent highlights the application of thiamphenicol and its derivatives in creating effective treatments for specific infections.

Career Highlights

Colombo is associated with Zambon Group S.p.a., a company known for its commitment to research and development in the pharmaceutical sector. His work at Zambon has allowed him to focus on innovative solutions that address pressing health issues.

Collaborations

Colombo has collaborated with esteemed colleagues such as Domenico Ungheri and Luciano Licciardello. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Giovanni Battista Colombo's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective treatments. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…